Schedule 13D ownership disclosure
LENZ THERAPEUTICS INC
Security class unavailable · CUSIP: 52635N103
Event date: 2024-08-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-254239
- Form type
- SC 13D
- Filer
- LENZ Therapeutics, Inc.
- CIK
- CIK 1815776
- Filed
- Nov 08, 2024
- Reporting period
- Aug 14, 2024
- Description
- Schedule 13D beneficial ownership